Academic Journal

Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL 1)

التفاصيل البيبلوغرافية
العنوان: Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL 1)
المؤلفون: Tripodi, Armando, Di Iorio, Giancarlo, Lippi, Giuseppe, Testa, Sophie, Manotti, Cesare
المصدر: Clinical Chemistry and Laboratory Medicine (CCLM) ; volume 50, issue 12, page 2137-2140 ; ISSN 1437-4331 1434-6621
بيانات النشر: Walter de Gruyter GmbH
سنة النشر: 2012
الوصف: At variance with vitamin K antagonists, the new oral anticoagulants (NOAs) can be prescribed at fixed dosage without adjustment by laboratory testing. However, this does not necessarily mean that the laboratory does not play a role for their management. This position paper represents the consensus document of three Italian scientific societies dealing with laboratory issues in thrombosis and hemostasis. It is aimed at reviewing: 1) which test(s) should be used to evaluate the anticoagulant effect of each of the NOAs presently available (i.e., dabigatran, rivaroxaban and apixaban); 2) the patients to be investigated; and 3) the timing of investigation.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1515/cclm-2012-0327
DOI: 10.1515/cclm-2012-0327/xml
DOI: 10.1515/cclm-2012-0327/pdf
الاتاحة: http://dx.doi.org/10.1515/cclm-2012-0327
https://www.degruyter.com/document/doi/10.1515/cclm-2012-0327/xml
https://www.degruyter.com/document/doi/10.1515/cclm-2012-0327/pdf
رقم الانضمام: edsbas.B48864EA
قاعدة البيانات: BASE